Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gish Biomedical's Vision cleared for marketing:

This article was originally published in Clinica

Executive Summary

Gish Biomedical's Vision oxygenator, a component of its cardiovascular bypass system that replaces lung function during surgery, has been cleared by the FDA for marketing in the US. The device enables exchange of oxygen and carbon dioxide, while regulating the patient's blood temperature. Gish Biomedical, based in Irvine, California, says that it will release the device early next year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089801

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel